Document is current
Any future updates will be listed below
-
Authors
Xie, Xinglei
Liu, Jiaming
García-Patterson, Apolonia
Chico, Ana
Mateu-Salat, Manel
Amigó, Judit
Adelantado, Juan María
Corcoy, Rosa https://orcid.org/0000-0001-5055-6814
- License Information
-
More Information
Article History
Received: 10 June 2023
Accepted: 4 October 2023
First Online: 16 October 2023
Declarations
:
: The study protocol was approved by the Ethics Committee of the Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau) (reference number IIBSP-IPE-2020-44).
: The Ethics Committee waived the requirement for informed consent.
: RC declares that she has received consultancy fees from Novo Nordisk and speakers’ fees or support for attending meetings or research from Novo Nordisk, Lilly, Sanofi, Roche, Medtronic, and Novalab-Air liquide. AC declares that she has received consultancy fees from Novo Nordisk, Lilly, and Abbott and speakers’ fees or support for attending meetings or research from Novo Nordisk, Lilly, Sanofi, Roche, Boehringer, Medtronic, and Novalab-Air liquide. All other authors declare that they have no competing interests.
